| Evaluation of Efficacy and Safety of THRV-1268 in Long QT Syndrome Type 2 (LQTS 2) (NCT07277582) | Thryv Therapeutics, Inc. | 2026-03-07 |
| Phase II Study of RC1416 Injection in COPD (NCT07402551) | Nanjing RegeneCore Biotech Co., Ltd. | 2026-03-06 |
| A Study of GenSci134 in Children With Growth Hormone Deficiency (PGHD) (NCT07450001) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2026-03-06 |
| Celecoxib Plus R-CHOP vs R-CHOP in Newly Diagnosed Advanced CD5+ DLBCL (NCT07494565) | Sun Yat-sen University | 2026-03-06 |
| Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region (NCT07370207) | AusperBio Therapeutics Inc. | 2026-03-06 |
| A Study (Phase 1b/2) of GenSci134 in Children With Idiopathic Short Stature (ISS) (NCT07450053) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2026-03-06 |
| Safety and Efficacy of HRS-9190 Compared to Rocuronium for Bolus Maintenance in Adults (NCT07404579) | Jiangsu HengRui Medicine Co., Ltd. | 2026-03-06 |
| SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma (NCT06822010) | Rutgers, The State University of New Jersey | 2026-03-06 |
| A Study of Terbium 161 (161Tb)-RAD402 in Participants With CRPC (NCT07259213) | Radiopharm Theranostics, Ltd | 2026-03-05 |
| QLS12010 in Participants With Moderate-to-severe Rheumatoid Arthritis (NCT07377773) | Qilu Pharmaceutical Co., Ltd. | 2026-03-05 |
| Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome (NCT07273838) | Yale University | 2026-03-05 |
| Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma (NCT07479732) | Peking University People's Hospital | 2026-03-05 |
| PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy (NCT07463248) | Wang Xin | 2026-03-05 |
| A Study to Evaluate SHR-1139 Injection in Patients With Pyoderma Gangrenosum (NCT07444684) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-03-05 |
| Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid Tumors. (NCT07644403) | Suzhou Immunofoco Biotechnology Co., Ltd | 2026-03-05 |
| A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood (NCT06241560) | Boehringer Ingelheim | 2026-03-05 |
| SKB105 for Injection in Advanced Solid Tumors (NCT07380386) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2026-03-05 |
| FMD and Neoadjuvant Chemo-immunotherapy in TNBC (NCT07378306) | Sun Yat-sen University | 2026-03-05 |
| A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) (NCT07450859) | BicycleTx Limited | 2026-03-05 |
| Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors. (NCT07303387) | Gustave Roussy, Cancer Campus, Grand Paris | 2026-03-05 |
| Aroxxen® Inhalation for Cardioprotection After Elective PCI With Stent Implantation (NCT07397351) | Research Institute of Geroprotective Technologies | 2026-03-05 |
| TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men (NCT07460960) | Lomonosov Moscow State University Medical Research and Educational Center | 2026-03-05 |
| A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight (NCT07441252) | Amgen | 2026-03-05 |
| Efficacy and Safety of Ribupatide (KAI-9531) Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes (NCT07458269) | Kailera | 2026-03-04 |
| A Clinical Trial to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis. (NCT07369076) | Nura Bio | 2026-03-04 |
| Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma (NCT07291297) | Wake Forest University Health Sciences | 2026-03-04 |
| Camrelizumab Plus Risedronate and Chemotherapy for Triple-Negative Breast Cancer: An Exploratory Clinical Study on Mechanisms and Efficacy (NCT07471815) | Harbin Medical University | 2026-03-04 |
| HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission (NCT07459673) | Memorial Sloan Kettering Cancer Center | 2026-03-04 |
| HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor (NCT07396584) | Hutchmed | 2026-03-04 |
| Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer (NCT06434064) | Roswell Park Cancer Institute | 2026-03-03 |
| Study of TGM-312-SC01 in Healthy Participants and Adults With MASH (NCT07427680) | Tangram Therapeutics Plc | 2026-03-03 |
| A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer (NCT07227025) | Janssen Research & Development, LLC | 2026-03-03 |
| ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression (NCT06408246) | Stanford University | 2026-03-03 |
| Efficacy of Tunlametinib in Combination With Anti-EGFR Monoclonal Antibody in Patients With RAS-Mutated Advanced Gastrointestinal Malignancies (NCT07446270) | Chinese PLA General Hospital | 2026-03-03 |
| A Clinical Study Evaluating the Efficacy and Safety of CMS-D001 Tablets in the Treatment of Adult Patients With Moderate to Severe Plaque-type Psoriasis (NCT07432854) | Dermavon Holdings Limited | 2026-03-03 |
| Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC (NCT07476001) | H. Lee Moffitt Cancer Center and Research Institute | 2026-03-03 |
| Efficacy and Safety of Oral Controlled-release Nicotinic Acid (CIR-NA) for the Remission of Prediabetes. (CONCEPT) (NCT07286747) | University Hospital Schleswig-Holstein | 2026-03-03 |
| A Study of Ziresovir (AK0529) in High-risk Adult With Respiratory Syncytial Virus (RSV) Infection. (NCT07658534) | Shanghai Ark Biopharmaceutical Co., Ltd. | 2026-03-03 |
| A Study of Bupivacaine Liposome Injection in the Treatment of Pain After Thoracoscopic Surgery (NCT06529432) | Jiangsu HengRui Medicine Co., Ltd. | 2026-03-03 |
| The Effect of Omega 3 Supplementation on Postoperative Delirium in Elderly Patients Undergoing Major Cardiac Surgery (NCT06434948) | University of Missouri-Columbia | 2026-03-03 |
| A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis (NCT07226895) | Monument Therapeutics Limited | 2026-03-03 |
| Phase 1/2 Study of EB-NK-301 (Allogeneic TROP2-CAR NK Cells) in Advanced TROP2-Expressing Solid Tumors (NCT07589530) | Beijing Biotech | 2026-03-02 |
| Intradialytic Exercise Combined With Creatine Monohydrate in Patients With Chronic Kidney Disease Undergoing Hemodialysis. (NCT07666815) | Pedro Julian Flores Moreno | 2026-03-02 |
| SHR-1701 in Combination With Stereotactic Body Radiotherapy in mCRPC (NCT07451795) | Fudan University | 2026-03-02 |
| Prospective IR-led Sedation Feasibility (NCT07443254) | CAMC Health System | 2026-03-02 |
| Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors (NCT07523529) | Beijing Biotech | 2026-03-02 |
| Dual-Target CLDN18.2/HER2 CAR-NK Cells for Advanced Esophageal Adenocarcinoma (NCT07622940) | Beijing Biotech | 2026-03-02 |
| A Study to Evaluate ALN-2232 in Participants With Obesity (NCT07463846) | Alnylam Pharmaceuticals | 2026-03-02 |
| A Study of AK112 in Combination With VG2025 in Colorectal Cancer With Liver Metastases (NCT07357220) | Akeso | 2026-03-02 |
| Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer (NCT07641036) | Beijing Biotech | 2026-03-02 |
| Dual-Target CAR-NK Cells in Recurrent or Refractory Epithelial Ovarian Cancer (NCT07589543) | Beijing Biotech | 2026-03-02 |
| Vitamin D3 for Moderate to Mild Traumatic Brain Injury: A Randomized Trial on Inflammation and Recovery (VIMOT) (NCT07269457) | Lagos State University | 2026-03-02 |
| Dual-target CLDN18.2/HER2 CAR-NK Cells for Advanced Gastric/GEJ Cancer (NCT07551362) | Beijing Biotech | 2026-03-02 |
| Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas (NCT07319676) | National University Hospital, Singapore | 2026-03-02 |
| Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma (NCT07510815) | Beijing Biotech | 2026-03-02 |
| A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 ) (NCT07417189) | Abbisko Therapeutics Co, Ltd | 2026-03-02 |
| Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies (NCT07523555) | Beijing Biotech | 2026-03-02 |
| SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus (NCT07523542) | Beijing Biotech | 2026-03-02 |
| Target-Selected CAR-NK Cells (CD30, CD5, or Mesothelin) for Relapsed/Refractory B2 Thymoma or Thymic Carcinoma (NCT07598955) | Beijing Biotech | 2026-03-02 |
| Pacritinib With Standard of Care Azacitidine or Decitabine as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant for Patients With Accelerated and Blast Phase Myeloproliferative Neoplasms (NCT07148947) | University of Washington | 2026-03-02 |
| Dual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma (NCT07627711) | Beijing Biotech | 2026-03-02 |
| H101 Plus TACE for r/m HNSCC (NCT07398664) | West China Hospital | 2026-03-02 |
| A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With or Without Comorbid Asthma (NCT07436949) | Bambusa Therapeutics | 2026-03-02 |
| Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) pt2 (NCT07617753) | Beijing Biotech | 2026-03-02 |
| Dual-Target CAR-NK Cells Targeting MSLN, EGFR, or HER2 in Advanced NSCLC (NCT07641023) | Beijing Biotech | 2026-03-02 |
| Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced Melanoma (NCT07627698) | Beijing Biotech | 2026-03-02 |
| Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma (NCT07502287) | Beijing Biotech | 2026-03-02 |
| Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC) (NCT07744256) | Beijing Biotech | 2026-03-02 |
| EGFR/HER2 Dual-Target CAR-NK Cells for Recurrent or Metastatic HNSCC (NCT07617805) | Beijing Biotech | 2026-03-02 |
| PRISM-NK: Precision-Matched Allogeneic Single- or Dual-Target CAR-NK Cells for Advanced Solid Tumors (NCT07510828) | Beijing Biotech | 2026-03-02 |
| Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC (NCT07500220) | Beijing Biotech | 2026-03-02 |
| NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial (NCT06821997) | Roswell Park Cancer Institute | 2026-03-02 |
| A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Seasonal Allergic Rhinitis (NCT07436234) | Akeso | 2026-03-02 |
| Albuminuria Reduction Study With Survodutide Treatment in Kidney Disease (NCT07206290) | University Medical Center Groningen | 2026-03-02 |
| Stereotactic Body Radiation Therapy (SBRT) and Immunotherapy for Oligometastatic Esophageal Cancer (NCT07330583) | AHS Cancer Control Alberta | 2026-03-01 |
| Anti-CD38 Monoclonal Antibody Combined With Rituximab in the Management of Primary Immune Thrombocytopenia (ITP) (NCT07362199) | Institute of Hematology & Blood Diseases Hospital, China | 2026-03-01 |
| An Efficacy and Safety Study of NTB003 in Participants With Thyroid Eye Disease (TED) (NCT07462130) | Nanjing Chia-tai Tianqing Pharmaceutical | 2026-03-01 |
| Short-course Radiotherapy in TNT Combined With Enlonstobart for pMMR LARC (NCT07448077) | Hebei Medical University Fourth Hospital | 2026-03-01 |
| Finding Links Between Hot flASHes and CardioVascular Disease (NCT07077395) | Massachusetts General Hospital | 2026-03-01 |
| Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque Psoriasis (NCT06723171) | Io Therapeutics | 2026-03-01 |
| Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder (NCT07405606) | Centre for Addiction and Mental Health | 2026-03-01 |
| Neuroprotection of Memantine and Rosuvastatin (NCT07504198) | Tanta University | 2026-03-01 |
| A Clinical Study of SH006 Injection in Combination Therapy Versus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma (NCT07392866) | Nanjing Sanhome Pharmaceutical, Co., Ltd. | 2026-03-01 |
| A Study of VCT220 in Participants With Hypertension and Obesity or Overweight (NCT07360275) | Vincentage Pharma Co., Ltd | 2026-03-01 |
| MLD10 for the Treatment of Hypomagnesemic Patients With Type 2 Diabetes Mellitus (NCT03567824) | Pharmalyte Solutions LLC | 2026-03-01 |
| Synergistic Minimally Invasive Surgery and Deferoxamine in ICH (NCT07162363) | University of Illinois at Chicago | 2026-03-01 |
| Focusing on the Menopausal Transition to Improve Mid-Life Women's Health (NCT06975111) | University of Colorado, Denver | 2026-03-01 |
| Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II Study (NCT05653635) | Centre Paul Strauss | 2026-03-01 |
| A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibody, ESG206, in Patients With Primary Sjogren Syndrome (NCT07375524) | Shanghai Escugen Biotechnology Co., Ltd | 2026-03-01 |
| IFN-α in Relapse Prevention. (NCT07449286) | Peking University People's Hospital | 2026-03-01 |
| Lenvatinib Plus PD-1 Inhibitor for Advanced Solid Tumors With 11q13 Amplification (NCT07417501) | Tongji Hospital | 2026-03-01 |
| A Phase II Study of Sintilimab Combined With Ipilimumab N01, Cetuximab and Dabrafenib in Patients With Microsatellite-Stable, BRAF V600E-Mutated Metastatic Colorectal Cancer (NCT07506109) | Tianjin Medical University Cancer Institute and Hospital | 2026-03-01 |
| Study on the Efficacy and Safety of JSKN016 as Neoadjuvant Therapy in Resectable Stage II-III Non-small Cell Lung Cancer Patients (NCT07493980) | Shanghai Pulmonary Hospital, Shanghai, China | 2026-03-01 |
| The Efficacy and Safety of Trastuzumab Rezetecan (SHR-A1811) in HER2-Low Unresectable/Metastatic Breast Cancer Patients With Visceral Crisis (NCT07203729) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-03-01 |
| GSL Synthetase Inhibitor Plus Immune Checkpoint Inhibitor and/or Regorafenib in Previously Treated pMMR/MSS CRC. (NCT06558773) | Chinese PLA General Hospital | 2026-03-01 |
| Lenvatinib and Pembrolizumab With or Without BCAA in Unresectable HCC (NCT07412054) | Fudan University | 2026-03-01 |
| Putting Children First - Parent Training for Parents in High Conflict (NCT06809153) | IRIS Media Inc | 2026-03-01 |
| The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy (NCT07475065) | Universitas Sebelas Maret | 2026-03-01 |
| Clinical Trial of TB511 in Advanced Solid Tumors (NCT06400160) | Twinpig Biolab, Inc. | 2026-03-01 |
| Timing Optimization of Immunotherapy During Neoadjuvant Chemotherapy for Locally Advanced Nasopharyngeal Carcinoma (NCT07388836) | Fujian Cancer Hospital | 2026-03-01 |